You can buy or sell GSK and other stocks, options, ETFs, and crypto commission-free!
GlaxoSmithKline plc, also called GlaxoSmithKline, is a global healthcare company which engages in developing, manufacturing, and marketing of pharmaceutical products including vaccines, over the counter medicines and health-related consumer products. It operates through the following segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. Read More The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Brentford, Greater London
52 Week High
52 Week Low
Research And Development
Health And Wellness
Yahoo FinanceMar 13
Worried about the State Pension? I think the GSK share price could help you retire early
The rising State Pension age is likely to be a continuing concern for people of all ages, as it’s due to increase to 68 over the next two decades.
PRESS DIGEST- British Business - March 13
March 13 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times - G4S Plc said on Tuesday it received bid interest in its cash-handling business, with contact coming from both private equity firms and rival companies. bit.ly/2XQkXAC - The Early Learning Centre toy business has been sold by Mothercare Plc to The Entertainer group as part of a restructuring of the struggling maternity...
Yahoo FinanceMar 12
GlaxoSmithKline (GSK) Stock Sinks As Market Gains: What You Should Know
GlaxoSmithKline (GSK) closed at $40.03 in the latest trading session, marking a -0.12% move from the prior day. GlaxoSmithKline (GSK) closed the most recent trading day at $40.03, moving -0.12% from the previous trading session. This change lagged the S&P 500's 0.3% gain on the day. At the same time, the Dow lost 0.38%, and the tech-heavy Nasdaq gained 0.44%. Coming into today, shares of the drug developer had lost 0.37% in the past month. In that same time, the Medical sector gained 2.07%, while the S&P ...
Available May 1